Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular Carcinoma

This study has been completed.
Information provided by (Responsible Party):
ShenFeng, Eastern Hepatobiliary Surgery Hospital Identifier:
First received: December 22, 2008
Last updated: March 30, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)